Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
about
Impact of inflammation on the osteoblast in rheumatic diseasesEarly anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.Discriminating Value of Calprotectin in Disease Activity and Progression of Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis.The genetic basis of ankylosing spondylitis: new insights into disease pathogenesisMagnetic resonance imaging findings in juvenile spondyloarthropathy and effects of treatment observed on subsequent imaging.Identification of potential transcriptomic markers in developing ankylosing spondylitis: a meta-analysis of gene expression profiles.Expression profiling in spondyloarthropathy synovial biopsies highlights changes in expression of inflammatory genes in conjunction with tissue remodelling genes.Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritisImmune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients.The danger model approach to the pathogenesis of the rheumatic diseases.Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression.Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade.Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes.To Wnt or not to Wnt: the bone and joint health dilemmaProgranulin knockout accelerates intervertebral disc degeneration in aging miceCausal analysis approaches in Ingenuity Pathway AnalysisVitamin D and spondyloarthritis.Mediators of inflammation and bone remodeling in rheumatic disease.Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.Pharmacological Value of Murine Delayed-type Hypersensitivity Arthritis: A Robust Mouse Model of Rheumatoid Arthritis in C57BL/6 Mice.The role of progranulin in arthritis.Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling.Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model.The Protective Effect of Chrysanthemum indicum Extract against Ankylosing Spondylitis in Mouse Models.Bone regeneration is associated with the concentration of tumour necrosis factor-α induced by sericin released from a silk mat.Downregulation of dickkopf-1 enhances the proliferation and osteogenic potential of fibroblasts isolated from ankylosing spondylitis patients via the Wnt/β-catenin signaling pathway in vitro.Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis.Possible role of Dickkopf-1 protein in the pathogenesis of tympanosclerosis in a rat model.The osteogenic potential of ligament fibroblasts is greater in ankylosing spondylitis patients than in patients with osteoarthritis.Protective Effects of Sinomenine Against Ankylosing Spondylitis and the Underlying Molecular Mechanisms.
P2860
Q26829246-B09C0A6F-A7CA-4730-9DE2-5795A0F0256FQ33742894-BF6BC583-822C-4139-9A36-1237DA48C4F5Q33775550-15DCB5AF-78E9-4E3C-A2A1-7B32A3D32048Q33806334-18D7BED3-9A7A-471F-859C-ABA2E2A117FFQ33948190-315A9897-504D-47CF-9241-37809CF84B12Q35061614-B44CC569-A2BB-457C-A349-B529BAA90AFFQ35065306-5D5986A5-BBEC-43E8-90DA-197ED353772BQ35345123-D1B3AE2F-9D2E-486C-9D2E-7719B40D12FEQ35531152-A900A175-3604-49CE-9415-074D8CE75959Q35564107-C578A32E-6B11-4A2A-B9BA-5F20DCFFC548Q35854185-F7390E10-220E-48D3-80A3-9DD26C5B0777Q35907743-D5656C73-AA4D-4AE3-83E4-025EC14B98F1Q36525920-240C5454-28BA-4D97-8AC8-369DB40DE745Q36794846-1F34EF96-F62A-46D8-8489-D88D8C167A05Q36972672-5BA64185-174B-46C9-9440-8D0C74DDF664Q37592031-E156F6BB-61C4-441B-8EEB-0DB8AC26E422Q38262855-3B28276B-6DED-4C35-A436-2B367D6C83E8Q38576851-68D27EC3-8317-46E0-BF19-A51DC9DC56ACQ38593977-1B498BD0-07D3-4904-BD6B-3FF411E0852BQ38828545-161DDF80-131D-4BAA-8E98-E317F3D1E8EAQ38922852-6C09B020-A44B-458F-8D2D-8104D198E790Q39918340-9BAC6127-45D2-4FCB-9013-E2A3866BBD11Q41067642-760B245C-D73B-408B-A371-3738D6DC46D5Q41524312-3099AE49-C0CB-4CCC-9869-843B3CECCFF3Q42045975-8CF178AF-9447-44BF-B697-60CE3C4908F6Q44631309-8FA8AE16-1495-47D7-9A21-BDF4EEFB3F8CQ46278792-5837C953-FD40-4E60-ACA0-216914FCB8C0Q47123994-1429610A-B78B-489A-B2FC-4CEC7E4B26E6Q47954815-298630FA-4335-4490-8621-92B2BCF0CEA7Q53541850-E5FABCA1-8547-4987-AA98-31009738C43CQ55251536-B67B9552-AC4E-47DC-99A4-034926E8555B
P2860
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Excessive bone formation in a ...... ases in Wnt pathway inhibitors
@en
type
label
Excessive bone formation in a ...... ases in Wnt pathway inhibitors
@en
prefLabel
Excessive bone formation in a ...... ases in Wnt pathway inhibitors
@en
P2093
P2860
P50
P356
P1476
Excessive bone formation in a ...... ases in Wnt pathway inhibitors
@en
P2093
Hsu-Wen Tseng
Katelin R Haynes
Tibor T Glant
P2860
P2888
P356
10.1186/AR4096
P577
2012-11-22T00:00:00Z
P5875
P6179
1027861626